An in vivo model for the neurodegenerative effects of beta amyloid and protection by substance P.

Por Kowall, N W, Beal, M F, Busciglio, J, Duffy, L K, Yankner, B A
Publicado em 1991

Impaired Brain Creatine Kinase Activity in Huntington's Disease

Por Zhang, S.F., Hennessey, T., Yang, L., Starkova, N.N., Beal, M.F., Starkov, A.A.
Publicado em 2011

Implanted fibroblasts genetically engineered to produce brain-derived neurotrophic factor prevent 1-methyl-4-phenylpyridinium toxicity to dopaminergic neurons in the rat.

Por Frim, D M, Uhler, T A, Galpern, W R, Beal, M F, Breakefield, X O, Isacson, O
Publicado em 1994

Chronic mitochondrial energy impairment produces selective striatal degeneration and abnormal choreiform movements in primates.

Por Brouillet, E, Hantraye, P, Ferrante, R J, Dolan, R, Leroy-Willig, A, Kowall, N W, Beal, M F
Publicado em 1995

Elevated free nitrotyrosine levels, but not protein-bound nitrotyrosine or hydroxyl radicals, throughout amyotrophic lateral sclerosis (ALS)-like disease implicate tyrosine nitrat...

Por Bruijn, L. I., Beal, M. F., Becher, M. W., Schulz, J. B., Wong, P. C., Price, D. L., Cleveland, D. W.
Publicado em 1997

INFLUENCE OF MITOCHONDRIAL ENZYME DEFICIENCY ON ADULT NEUROGENESIS IN MOUSE MODELS OF NEURODEGENERATIVE DISEASES

Por CALINGASAN, N. Y., HO, D. J., WILLE, E. J., CAMPAGNA, M. V., RUAN, J., DUMONT, M., YANG, L., SHI, Q., GIBSON, G. E., BEAL, M. F.
Publicado em 2008

Activation of sirtuin 1 as therapy for the peroxisomal disease adrenoleukodystrophy

Por Morató, L, Ruiz, M, Boada, J, Calingasan, N Y, Galino, J, Guilera, C, Jové, M, Naudí, A, Ferrer, I, Pamplona, R, Serrano, M, Portero-Otín, M, Beal, M F, Fourcade, S, Pujol, A
Publicado no Cell Death Differ (2015)